Learn
Looking for more information?
Contact our responsive and friendly client services team any time.
Current price
$0.011
▾0.00 (0.00%)
Last trade: 19/04, 4:16AM
Market cap
$4.83m
Trading Suspended
Talk to Exopharm Limited directly.
Sign up to their Investor Hub for direct access to the Exopharm Limited team, ask them questions, and see personal updates.
Investor Presentations
Principal Activity
Exopharm’s primary focus is to be a leader in the field of clinical human therapeutics using exosomes as regenerative medicine products. Exopharm is an Australian biopharmaceutical company that is seeking to develop and then commercialise exosomes as therapeutic agents – initially a product called Plexaris and later as a product called Exomeres – both being exosomes that are purified using the LEAP technology owned by Exopharm, its key asset.
Address
Level 1/888 Doncaster Rd, Doncaster East VIC 3109, Australia
Website
News
Announcements
Filter
Announcement | T+2 Movement | Date |
---|---|---|
Market Data
Day
3m
1yr
5yr
Current price
$0.011
Open price
-
Day low-high
-
Price change
Percent change
Previous close
-
Volume
-
Turnover
-
Bid price
-
Ask price
-
Market cap
-
Shares outstanding
-
Year high
-
Year low
-
Year low-high
-
Earnings per share
-
Price/earnings ratio
-
Dividend yield
-
Dividend per share
-
Franking
-
Investor Presentations
News
Sector Peers
Company | Market Cap | ||
---|---|---|---|
Support
Live Chat
Markets